StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Merck (MRK) PT Raised to $170 at Guggenheim
September 8, 2026 7:16 AM
(Updated - September 8, 2026 7:19 AM EDT)
Guggenheim analyst Vamil Divan raised the price target on Merck (NYSE ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change